ARC Desk

By 2026 Biopharmaceutical Excipients Market to Reach $ 3.3 Billion, Globally

Lehdistötiedote   •   Elo 23, 2019 09:30 EEST

According to Acumen Research and Consulting, the Global Biopharmaceutical Excipients Market is expected to reach $3.3 billion by 2026 growing at a CAGR of 6.9% from 2018 to 2026.

Market Overview:

Biopharmaceutical Excipients Market 2018 - 2026 research report includes the SWOT analysis that's Strengths, Weakness, Opportunities and Threats which provides you complete analysis of competitors, market growth, market share and in addition as CAGR comparison by region. The report provides analysis of the global Biopharmaceutical Excipients Market for the period from 2016 to 2026, wherein 2018–2026 is the forecast period and 2018 is the base year. Data for 2017 has been included as historical information.

The report covers all trends and technologies expected to play a major role in growth of the global Biopharmaceutical Excipients Market during the forecast period. It highlights drivers, restraints, and opportunities expected to influence the market from 2018 to 2026. The study provides a holistic perspective on the Biopharmaceutical Excipients Market, in terms of revenue (in US$ Mn) and volume (in million units), across different regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South America. The report highlights key trends affecting the Biopharmaceutical Excipients Market at the global level. Prominent countries/sub-regions covered in the report include the U.S., Canada, Germany, France, the U.K., Italy, Russia, India, China, Japan, South Korea, South East Asia, GCC, South Africa, and Brazil.

Download Free Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1106

The report comprises detailed ecosystem analysis, which provides a comprehensive view of the global Biopharmaceutical Excipients Market. Porter’s five forces model has also been included to help understand the competition landscape of the market. Additionally, current indicators of diverse macro-economic factors are contextualized under key market indicators.

The report also analyzes the Biopharmaceutical Excipients Market on the basis of various segments. A unique section in the report also offers a detailed breakdown on the basis of route of administration – which one is highly preferred and which one is minimally preferred.

Scope of the Biopharmaceutical Excipients Market Report:

The study provides a decisive view of the Biopharmaceutical Excipients Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Market Segmentation:

Market By Product

  • Solubilizers& Surfactants/Emulsifiers
    • Triglycerides
    • Esters
    • Others
  • Polyols
    • Mannitol
    • Sorbitol
    • Others
  • Carbohydrates
    • Sucrose
    • Dextrose
    • Starch
    • Others
  • Specialty Biopharmaceutical Excipients/Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

Europe represented the biggest offer of the worldwide market in 2018, trailed by North America. Presence of enhanced providers and strong research financing in chemicals division has come about into the evaluated offer of these areas in worldwide revenue. Development prospects for this industry in these business sectors are anticipated to be moderate in the coming years.

Developing markets, for example, India, China, and South Korea, are anticipated to observe worthwhile development. The foreseen increase in demand after and sales for raw materials in these business sectors, can be credited to the developing biopharmaceutical industry and extending business impression of organizations in the Asian nations.

Market Participants / Key Players:

The key companies catering in the global biopharmaceutical excipients market are BASF SE; ABITEC Corp.; Spectrum Chemical Manufacturing Corp; Signet Chemical Corporation Pvt. Ltd.; Pharmonix Biological Pvt. Ltd.; Roquette; SPI Pharma; Sigachi Industries Pvt. Ltd.; IMCD; Meggle AG; Clariant; Colorcon, Inc.; and DFE Pharma.

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

What is the overall structure of the market?

What was the historical value and what is the forecasted value of the market?

What are the key product level trends in the market?

What are the market level trends in the market?

Which of the market players are leading and what are their key differential strategies to retain their stronghold?

Which are the most lucrative regions in the market space?

Research Methodology

Secondary research sources that are typically referred to include, but are not limited to company websites, annual reports, financial reports, broker reports, investor presentations, SEC filings, internal and external proprietary databases, relevant patent and regulatory databases, national government documents, statistical databases, market reports, news articles, press releases, webcasts specific to companies operating in the market, national government documents, statistical databases, and Factiva.

Primary research involves e-mail interactions, telephonic interviews, and face-to-face interviews conducted for each market segment across geographies. ARC conducts primary interviews on an ongoing basis with market participants and commentators in order to validate the data and analysis. Primary interviews provide firsthand information on market size, market trends, growth trends, competition landscape, and market outlook. These help validate and strengthen secondary research findings. They also help develop the analysis team’s expertise and market understanding.

VIEW FULL RESEARCH REPORT@ https://www.acumenresearchandconsulting.com/biopharmaceutical-excipients-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Biopharmaceutical Excipients
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Biopharmaceutical Excipients Market By Product
1.2.2.1. Global Biopharmaceutical Excipients Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Biopharmaceutical Excipients Market Revenue Share By Product in 2017
1.2.2.3. Solubilizers& Surfactants/Emulsifiers
1.2.2.4. Polyols
1.2.2.5. Carbohydrates
1.2.2.6. Specialty Biopharmaceutical Excipients
1.2.2.7. Others
1.2.3. Biopharmaceutical Excipients Market by Geography
1.2.3.1. Global Biopharmaceutical Excipients Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.3.2. North America Biopharmaceutical Excipients Market Revenue and Growth Rate (2015-2026)
1.2.3.3. Europe Biopharmaceutical Excipients Market Revenue and Growth Rate (2015-2026)
1.2.3.4. Asia-Pacific Biopharmaceutical Excipients Market Revenue and Growth Rate (2015-2026)
1.2.3.5. Latin America Biopharmaceutical Excipients Market Revenue and Growth Rate (2015-2026)
1.2.3.6. Middle East and Africa (MEA) Biopharmaceutical Excipients Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Biopharmaceutical Excipients Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Biopharmaceutical Excipients Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Biopharmaceutical Excipients Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Biopharmaceutical Excipients Major Manufacturers in 2017

CHAPTER 4. BIOPHARMACEUTICAL EXCIPIENTS MARKET BY PRODUCT

4.1. Global Biopharmaceutical Excipients Revenue By Product
4.2. Solubilizers& Surfactants/Emulsifiers
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Polyols
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Carbohydrates
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Specialty Biopharmaceutical Excipients
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Others
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. NORTH AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY

5.1. North America Biopharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2. North America Biopharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
5.3. U.S.
5.3.1. U.S. Biopharmaceutical Excipients Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.4. Canada
5.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.5. Mexico
5.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 6. EUROPE BIOPHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY

6.1. Europe Biopharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. Europe Biopharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. UK
6.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.4. Germany
6.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.5. France
6.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.6. Spain
6.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.7. Rest of Europe
6.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 7. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY

7.1. Asia-Pacific Biopharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Asia-Pacific Biopharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. China
7.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Japan
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. India
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.6. Australia
7.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.7. South Korea
7.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.8. Rest of Asia-Pacific
7.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 8. LATIN AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY

8.1. Latin America Biopharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Latin America Biopharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. Brazil
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Argentina
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. Rest of Latin America
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 9. MIDDLE EAST BIOPHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY

9.1. Middle East Biopharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Middle East Biopharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Saudi Arabia
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. UAE
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. Rest of Middle East
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 10. AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY

10.1. Africa Biopharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Africa Biopharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. South Africa
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. Egypt
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Africa
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE

11.1. BASF SE
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. ABITEC Corp.
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Spectrum Chemical Manufacturing Corp
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Signet Chemical Corporation Pvt. Ltd.
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. Pharmonix Biological Pvt. Ltd.
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Roquette
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. SPI Pharma
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Sigachi Industries Pvt. Ltd.
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. IMCD
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. Meggle AG
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
11.11. Clariant
11.11.1. Company Snapshot
11.11.2. Overview
11.11.3. Financial Overview
11.11.4. Product Portfolio
11.11.5. Key Developments
11.11.6. Strategies
11.12. Colorcon, Inc.
11.12.1. Company Snapshot
11.12.2. Overview
11.12.3. Financial Overview
11.12.4. Product Portfolio
11.12.5. Key Developments
11.12.6. Strategies
11.13. DFE Pharma
11.13.1. Company Snapshot
11.13.2. Overview
11.13.3. Financial Overview
11.13.4. Product Portfolio
11.13.5. Key Developments
11.13.6. Strategies
11.14. Others
11.14.1. Company Snapshot
11.14.2. Overview
11.14.3. Financial Overview
11.14.4. Product Portfolio
11.14.5. Key Developments
11.14.6. Strategies

CHAPTER 12. RESEARCH APPROACH

12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1106

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.